PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.
about
Challenges in clinical prostate cancer: role of imaging.Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative AnalysisManagement of biochemical recurrence after primary localized therapy for prostate cancerRising prostate-specific antigen after primary prostate cancer therapy.Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Dendritic cells serve as a "Trojan horse" for oncolytic adenovirus delivery in the treatment of mouse prostate cancerEarly dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial.Oncologic applications of diffusion-weighted MRI in the body.Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.Prostate cancer vaccines in combination with additional treatment modalities.L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.Bad expression influences time to androgen escape in prostate cancer.Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial.The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.Salvage radiation in men after prostate-specific antigen failure and the risk of death.Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer?Androgen deprivation and immunotherapy for the treatment of prostate cancer
P2860
Q33945133-EE03FA9B-8EC6-42C9-BA8F-1976BE38A534Q35582358-7F8028D0-F983-4BE9-B0D4-A7B4D11677C4Q35981941-ABE15DB8-AF74-43A0-B273-1C377E8AEB7EQ36395149-DAD0E916-11C7-49E8-B7F3-A4503E8BE7BEQ36795496-30E33658-8136-4285-870B-5AE457D2104CQ37151620-D5956DBB-8932-4404-8F9B-84A9EDC041FFQ37671710-F513AB97-DE21-461F-8E6C-FE3877E2B53AQ37978220-4382EFF3-3913-42DB-9FB0-2E11EA23422FQ38180344-075959D8-00D9-4FF2-BEF6-1C9A8CFC7429Q38190115-2A76D68A-0AA3-44C3-94B9-42B49F3F9C46Q38212571-A0548AF6-5D29-47ED-8BBD-BB7EE0D8CBB1Q40034822-50CE5028-7245-4562-B2CC-55030138F0A7Q40207434-D5DFA99E-612A-4B3F-B859-96D11C95A013Q40657628-42F9D444-D69C-4583-A28E-352FABF540D4Q41948740-054C691E-B3C7-4E7B-8215-C898652E32C3Q43625657-A829641D-700F-46A0-A9A0-D07A286D2513Q43902806-737E6D74-95FF-4946-9685-27140E848102Q57115565-01C3B53E-103F-46B5-BC48-E607FFD8F0F1
P2860
PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
PSA progression following radi ...... andards in the new Millennium.
@ast
PSA progression following radi ...... andards in the new Millennium.
@en
type
label
PSA progression following radi ...... andards in the new Millennium.
@ast
PSA progression following radi ...... andards in the new Millennium.
@en
prefLabel
PSA progression following radi ...... andards in the new Millennium.
@ast
PSA progression following radi ...... andards in the new Millennium.
@en
P2093
P1433
P1476
PSA progression following radi ...... andards in the new Millennium.
@en
P2093
Alexandre Zlotta
Bob Djavan
Judd W Moul
Mesut Remzi
P356
10.1016/S0302-2838(02)00505-5
P407
P577
2003-01-01T00:00:00Z